Rxight Pharmacogenetics from MD Labs

Rxight, developed by MD Labs, is a pharmacogenetic program that helps patients get the right medication at the right dose, the first time, based on their genetic profile. Importantly, Rxight also helps patients avoid medications that are ineffective or could cause dangerous side effects or adverse drug reactions. The MD Labs Rxight team was invited to the White House to present this novel Precision Medicine program to the Office of Science and Technology Policy. Go to our website to learn more. MD Labs was founded in 2011 with the goal to specialize in prescription monitoring toxicology and serve physicians across the United States. Our founders, Matthew Rutledge and Denis Grizelj started the company with the goal of creating a more provider-friendly testing service that prides itself on delivering prompt, accurate, reliable and easy to understand results.